Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use

Abstract Background Limited outcome data exist regarding partial-oral antibiotic therapy, defined as oral antibiotics as part of a patient's treatment, for bone and joint infections (BJIs) in people who inject drugs (PWID). Methods We conducted a retrospective study of all PWID reporting drug use within 3 months and BJIs requiring ≥6 weeks of antibiotics in an urban safety-net hospital between February 1, 2019, and February 1, 2021. Treatment outcomes were assessed by chart review. Rates of failure, defined as death, symptoms, or signs concerning for worsening or recurrent infections, were assessed 90 and 180 days after completion of antibiotics. Univariate logistic regression was used to explore the association between covariates and failure. Results Of 705 patients with BJI, 88 (13%) were PWID. Eighty-six patients were included in the final cohort. Forty-four (51%) were homeless, 50 (58%) had spine infection, 68 (79%) had surgery, and 32 of 68 (47%) had postoperatively retained hardware. Twelve (14%) of 86 patients received exclusively intravenous (IV) antibiotics, and 74 (86%) received partial-oral antibiotics. Twelve (14%) of 86 patients had patient-directed discharge. In those who received partial-oral antibiotics, the failure rate was 20% at 90 days and 21% at 180 days after completion of intended treatment. Discharge to a medical respite and follow-up with infectious diseases (ID) or surgery were negatively associated with odds of failure. Conclusions Partial-oral treatment of BJI in PWID was a common practice and often successful when paired with medical respite and follow-up with ID or surgery.

[1]  J. Marschall,et al.  Outcomes of Partial Oral Antibiotic Treatment for Complicated S. aureus Bacteremia in People Who Inject Drugs. , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  S. Liang,et al.  Patients With Serious Injection Drug Use–Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care , 2022, Open forum infectious diseases.

[3]  E. Stenehjem,et al.  A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs , 2021, Open forum infectious diseases.

[4]  H. Englander,et al.  “OPTIONS-DC”, a feasible discharge planning conference to expand infection treatment options for people with substance use disorder , 2021, BMC Infectious Diseases.

[5]  S. Dhanireddy,et al.  Evaluation of Bundled Interventions for Patients With Opioid Use Disorder Experiencing Homelessness Receiving Extended Antibiotics for Severe Infection , 2021, Open forum infectious diseases.

[6]  B. Giraudeau,et al.  Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. , 2021, The New England journal of medicine.

[7]  D. Rosenstein,et al.  Against Medical Advice Discharge: A Narrative Review and Recommendations for a Systematic Approach. , 2021, The American journal of medicine.

[8]  E. Suarez,et al.  Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team , 2021, Annals of medicine.

[9]  M. Veve,et al.  Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis. , 2020, The Journal of infectious diseases.

[10]  C. del Rio,et al.  Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA’s Advocacy Agenda , 2020, The Journal of infectious diseases.

[11]  T. Jenkins,et al.  Outpatient Antimicrobial Treatment for People Who Inject Drugs. , 2020, Infectious disease clinics of North America.

[12]  A. Wurcel,et al.  Hospital Stays and Medical Expenses Increase Nationwide Among Patients With Septic Arthritis of the Shoulder Who Inject Drugs. , 2020, Orthopedics.

[13]  J. Ross,et al.  Septic Arthritis and the Opioid Epidemic: 1465 Cases of Culture-Positive Native Joint Septic Arthritis From 1990–2018 , 2020, Open forum infectious diseases.

[14]  A. Westfall,et al.  In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections , 2020, Open Forum Infectious Diseases.

[15]  A. Wurcel,et al.  Injection Drug Use in Patients with Spinal Epidural Abscess: Nationwide Data, 2000-2013. , 2020, Spine.

[16]  S. Wakeman,et al.  Understanding why Patients with Substance use Disorders Leave the Hospital against Medical Advice: A Qualitative Study , 2019, Substance abuse.

[17]  A. Briggs,et al.  Oral versus Intravenous Antibiotics for Bone and Joint Infection , 2019, The New England journal of medicine.

[18]  S. Matsuzaka,et al.  Anti-racism and substance use treatment: Addiction does not discriminate, but do we? , 2019, Journal of ethnicity in substance abuse.

[19]  A. Jandourek,et al.  Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety , 2018, Open forum infectious diseases.

[20]  A. Wurcel,et al.  Increased Mortality and Reoperation Rates After Treatment for Septic Arthritis of the Knee in People Who Inject Drugs: Nationwide Inpatient Sample, 2000-2013 , 2018, Clinical orthopaedics and related research.

[21]  M. Golden,et al.  The Max Clinic: Medical Care Designed to Engage the Hardest‐to‐Reach Persons Living with HIV in Seattle and King County, Washington , 2018, AIDS patient care and STDs.

[22]  T. Rummans,et al.  The cost of a recalcitrant intravenous drug user with serial cases of endocarditis: Need for guidelines to improve the continuum of care , 2017, IDCases.

[23]  R. Lewis,et al.  Confounding by Indication in Clinical Research. , 2016, JAMA.

[24]  T. Dellit,et al.  Successful implementation of outpatient parenteral antimicrobial therapy at a medical respite facility for homeless patients. , 2016, Journal of hospital medicine.

[25]  A. Karchmer,et al.  Suboptimal Addiction Interventions for Patients Hospitalized with Injection Drug Use-Associated Infective Endocarditis. , 2016, The American journal of medicine.

[26]  J. Baldassarre,et al.  Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue , 2015, Antimicrobial Agents and Chemotherapy.

[27]  E. Wood,et al.  Hospitals as a 'risk environment': an ethno-epidemiological study of voluntary and involuntary discharge from hospital against medical advice among people who inject drugs. , 2014, Social science & medicine.

[28]  Benjamin A Lipsky,et al.  Systemic antibiotic therapy for chronic osteomyelitis in adults. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.